• Info
  • Significant Ownership

Significant Ownership of ILJIN SNT Co., Ltd.

Signature - Title
/s/ Tae Wan Kim - Tae Wan Kim/Authorized Signatory
Location
Seoul, Korea, Republic of
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ILJIN SNT Co., Ltd..

Notify me when ILJIN SNT Co., Ltd. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of ILJIN SNT Co., Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AUPH Aurinia Pharmaceuticals Inc. Common Shares, no par value 5% $80,186,180 6,535,141 Chin Kyu Huh 11 Aug 2025

Schedules 13D/G Reported by ILJIN SNT Co., Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.